| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adaptive treatments show promise in breast cancer
|
Baker, Holly
|
|
2016
|
17 |
8 |
p. e327-
1 p.
|
artikel
|
| 2 |
A prognostically relevant miRNA signature for epithelial ovarian cancer
|
Cramer, Daniel W
|
|
2016
|
17 |
8 |
p. 1032-1033
2 p.
|
artikel
|
| 3 |
Attitudes and practices towards legal euthanasia
|
Burki, Talha Khan
|
|
2016
|
17 |
8 |
p. e325-
1 p.
|
artikel
|
| 4 |
A Woman Like Me
|
Kinsey, Caroline Anne
|
|
2016
|
17 |
8 |
p. 1041-
1 p.
|
artikel
|
| 5 |
Beauty After Breast Cancer
|
Denny, Victoria
|
|
2016
|
17 |
8 |
p. 1044-
1 p.
|
artikel
|
| 6 |
Bendamustine combined regimen for Hodgkin's lymphoma
|
Venkatesan, Priya
|
|
2016
|
17 |
8 |
p. e326-
1 p.
|
artikel
|
| 7 |
Boy meets girl, girl gets cancer
|
Murdy, Abigail Grace
|
|
2016
|
17 |
8 |
p. 1045-
1 p.
|
artikel
|
| 8 |
Brazilian health-care policy for targeted oncology therapies and companion diagnostic testing
|
Ferreira, Carlos Gil
|
|
2016
|
17 |
8 |
p. e363-e370
nvt p.
|
artikel
|
| 9 |
BRCA mutations and risk of uterine cancer
|
Tanday, Sanjay
|
|
2016
|
17 |
8 |
p. e324-
1 p.
|
artikel
|
| 10 |
Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study
|
Bernardi, Daniela
|
|
2016
|
17 |
8 |
p. 1105-1113
9 p.
|
artikel
|
| 11 |
Combination chemotherapy for relapsed small-cell lung cancer
|
Kalemkerian, Gregory P
|
|
2016
|
17 |
8 |
p. 1033-1035
3 p.
|
artikel
|
| 12 |
Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG0605): a multicentre, open-label, randomised phase 3 trial
|
Goto, Koichi
|
|
2016
|
17 |
8 |
p. 1147-1157
11 p.
|
artikel
|
| 13 |
Combined modality adjuvant therapy for high-risk endometrial cancer
|
Vanderstichele, Adriaan
|
|
2016
|
17 |
8 |
p. 1029-1030
2 p.
|
artikel
|
| 14 |
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
|
Dearnaley, David
|
|
2016
|
17 |
8 |
p. 1047-1060
14 p.
|
artikel
|
| 15 |
Correction to Lancet Oncol 2016; 17: 1163, 1165
|
|
|
2016
|
17 |
8 |
p. e321-
1 p.
|
artikel
|
| 16 |
Correction to Lancet Oncol 2015; 16: 733
|
|
|
2016
|
17 |
8 |
p. e321-
1 p.
|
artikel
|
| 17 |
Correction to Lancet Oncol 2016; 17:1055
|
|
|
2016
|
17 |
8 |
p. e321-
1 p.
|
artikel
|
| 18 |
Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study
|
Bagnoli, Marina
|
|
2016
|
17 |
8 |
p. 1137-1146
10 p.
|
artikel
|
| 19 |
Early treatment for high-risk smouldering myeloma: has the time come?
|
Ludwig, Heinz
|
|
2016
|
17 |
8 |
p. 1030-1032
3 p.
|
artikel
|
| 20 |
Embroidered Cancer Comic
|
Short, Jessica
|
|
2016
|
17 |
8 |
p. 1044-
1 p.
|
artikel
|
| 21 |
ESMO World Congress on Gastrointestinal Cancer 2016
|
Carlson, Robert
|
|
2016
|
17 |
8 |
p. 1040-
1 p.
|
artikel
|
| 22 |
High frequency of gene mutations in metastatic prostate cancer
|
Wilkinson, Emma
|
|
2016
|
17 |
8 |
p. e326-
1 p.
|
artikel
|
| 23 |
Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial
|
Incrocci, Luca
|
|
2016
|
17 |
8 |
p. 1061-1069
9 p.
|
artikel
|
| 24 |
Hypofractionation for prostate cancer: tested and proven
|
Lee, W Robert
|
|
2016
|
17 |
8 |
p. 1020-1022
3 p.
|
artikel
|
| 25 |
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
|
Kumar, Shaji
|
|
2016
|
17 |
8 |
p. e328-e346
nvt p.
|
artikel
|
| 26 |
Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial
|
Mateos, María-Victoria
|
|
2016
|
17 |
8 |
p. 1127-1136
10 p.
|
artikel
|
| 27 |
Novel therapeutic targets on the horizon for lung cancer
|
Tan, Wan-Ling
|
|
2016
|
17 |
8 |
p. e347-e362
nvt p.
|
artikel
|
| 28 |
Obinutuzumab plus bendamustine in rituximab-refractory indolent lymphoma
|
Hamlin, Paul A
|
|
2016
|
17 |
8 |
p. 1023-1025
3 p.
|
artikel
|
| 29 |
Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial
|
Sehn, Laurie H
|
|
2016
|
17 |
8 |
p. 1081-1093
13 p.
|
artikel
|
| 30 |
Pembrolizumab for classical Hodgkin's lymphoma
|
Burki, Talha Khan
|
|
2016
|
17 |
8 |
p. e324-
1 p.
|
artikel
|
| 31 |
Progression-free survival landmark analysis: a critical endpoint in melanoma clinical trials
|
Ascierto, Paolo A
|
|
2016
|
17 |
8 |
p. 1037-1039
3 p.
|
artikel
|
| 32 |
Progression-free survival with regorafenib in gastric cancer
|
Burki, Talha Khan
|
|
2016
|
17 |
8 |
p. e323-
1 p.
|
artikel
|
| 33 |
Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial
|
Clive, Amelia O
|
|
2016
|
17 |
8 |
p. 1094-1104
11 p.
|
artikel
|
| 34 |
Quality of life after video-assisted surgery for lung cancer
|
Nakazawa, Seshiru
|
|
2016
|
17 |
8 |
p. e318-
1 p.
|
artikel
|
| 35 |
Quality of life after video-assisted surgery for lung cancer
|
The VIOLET trialists (correspondence to Eric lim),
|
|
2016
|
17 |
8 |
p. e317-
1 p.
|
artikel
|
| 36 |
Quality of life after video-assisted surgery for lung cancer
|
Veronesi, Giulia
|
|
2016
|
17 |
8 |
p. e316-e317
nvt p.
|
artikel
|
| 37 |
Quality of life after video-assisted surgery for lung cancer
|
Mehran, Reza J
|
|
2016
|
17 |
8 |
p. e315-e316
nvt p.
|
artikel
|
| 38 |
Quality of life after video-assisted surgery for lung cancer – Author's reply
|
Licht, Peter Bjørn
|
|
2016
|
17 |
8 |
p. e318-e319
nvt p.
|
artikel
|
| 39 |
Radiotherapy to intervention sites in mesothelioma: no more?
|
Ceresoli, Giovanni Luca
|
|
2016
|
17 |
8 |
p. 1025-1027
3 p.
|
artikel
|
| 40 |
Reconstruction through fragmentation
|
Swain, Kelley
|
|
2016
|
17 |
8 |
p. 1043-
1 p.
|
artikel
|
| 41 |
Reducing radiation doses for breast tomosynthesis?
|
Yaffe, Martin J
|
|
2016
|
17 |
8 |
p. 1027-1029
3 p.
|
artikel
|
| 42 |
Salvage radiotherapy for patients with rising PSA
|
Fossati, Nicola
|
|
2016
|
17 |
8 |
p. e314-e315
nvt p.
|
artikel
|
| 43 |
Salvage radiotherapy for patients with rising PSA – Authors' reply
|
Carrie, Christian
|
|
2016
|
17 |
8 |
p. e315-
1 p.
|
artikel
|
| 44 |
Shooting for the moon, and the stars?
|
The Lancet Oncology,
|
|
2016
|
17 |
8 |
p. 1019-
1 p.
|
artikel
|
| 45 |
Targeting PADI2 could stop the progression of myeloma
|
Tanday, Sanjay
|
|
2016
|
17 |
8 |
p. e325-
1 p.
|
artikel
|
| 46 |
Tasquinimod treatment for prostate cancer
|
Brower, Vicki
|
|
2016
|
17 |
8 |
p. e322-
1 p.
|
artikel
|
| 47 |
The case for informative phase 2 trials in osteosarcoma
|
Janeway, Katherine A
|
|
2016
|
17 |
8 |
p. 1022-1023
2 p.
|
artikel
|
| 48 |
The C Word
|
Clark, Jocalyn
|
|
2016
|
17 |
8 |
p. 1046-
1 p.
|
artikel
|
| 49 |
The mastectomy myth
|
McCormick, Beryl
|
|
2016
|
17 |
8 |
p. 1035-1037
3 p.
|
artikel
|
| 50 |
Timing of androgen-deprivation therapy for prostate cancer: still a long way to go
|
Fossati, Nicola
|
|
2016
|
17 |
8 |
p. e313-
1 p.
|
artikel
|
| 51 |
Timing of androgen-deprivation therapy for prostate cancer: still a long way to go – Authors' reply
|
Duchesne, Gillian M
|
|
2016
|
17 |
8 |
p. e313-e314
nvt p.
|
artikel
|
| 52 |
Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial
|
de Boer, Stephanie M
|
|
2016
|
17 |
8 |
p. 1114-1126
13 p.
|
artikel
|
| 53 |
Transoral robotic surgery for oropharyngeal cancer
|
Gilbert, Judith A
|
|
2016
|
17 |
8 |
p. e323-
1 p.
|
artikel
|
| 54 |
Using PET–CT to tailor treatment for Hodgkin's lymphoma
|
Tanday, Sanjay
|
|
2016
|
17 |
8 |
p. e322-
1 p.
|
artikel
|
| 55 |
Venetoclax in cancer therapy and potential effects on bone
|
Zaman, Farasat
|
|
2016
|
17 |
8 |
p. e319-e320
nvt p.
|
artikel
|
| 56 |
When cancer gets gnarly
|
Murdy, Abigail Grace
|
|
2016
|
17 |
8 |
p. 1042-
1 p.
|
artikel
|
| 57 |
10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study
|
van Maaren, Marissa C
|
|
2016
|
17 |
8 |
p. 1158-1170
13 p.
|
artikel
|
| 58 |
Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial
|
Piperno-Neumann, Sophie
|
|
2016
|
17 |
8 |
p. 1070-1080
11 p.
|
artikel
|
Tijdschrift beschrijving